Argyris Michalopoulos
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 32
-
- Antibiotic Use and Resistance 10
-
- Nosocomial Infections in ICU 20
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 22
- Endocrinology top 1%
-
- Pneumonia and Respiratory Infections 21
- Sepsis Diagnosis and Treatment 8
-
- Cardiac, Anesthesia and Surgical Outcomes 16
-
- Antifungal resistance and susceptibility 8
- Co-authors
- Matthew E. FalagasPetros I. RafailidisSofia K. KasiakouGeorge SamonisIoannis A. BliziotisStefanos GeroulanosDrosos E. KarageorgopoulosSpyros D. Mentzelopoulos
- Cited by
- Molecular MedicineApplied Microbiology and BiotechnologyCritical Care and Intensive Care Medicine
- Partner nations
- GreeceUnited StatesItaly
In The Last Decade
Argyris Michalopoulos
97 papers receiving 6.0k citations
Peers
Comparison fields: 5 of 170
- Molecular Medicine 2.9k
- Applied Microbiology and Biotechnology 835
- Critical Care and Intensive Care Medicine 1.0k
- Pharmacology 1.8k
- Endocrinology 456
Countries citing papers authored by Argyris Michalopoulos
This map shows the geographic impact of Argyris Michalopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Argyris Michalopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Argyris Michalopoulos more than expected).
Fields of papers citing papers by Argyris Michalopoulos
This network shows the impact of papers produced by Argyris Michalopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Argyris Michalopoulos. The network helps show where Argyris Michalopoulos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Argyris Michalopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 291 | |
| 2 | 2010 | 16 | |
| 3 | 2010 | 50 | |
| 4 | 2009 | 136 | |
| 5 | 2009 | 244 | |
| 6 | 2009 | 35 | |
| 7 | 2009 | 151 | |
| 8 | 2008 | 155 | |
| 9 | 2008 | 105 | |
| 10 | 2006 | 70 | |
| 11 | 2006 | 80 | |
| 12 | 2006 | 102 | |
| 13 | 2006 | 52 | |
| 14 | 2005 | 5 | |
| 15 | 2005 | 206 | |
| 16 | 2005 | 309 | |
| 17 | 2002 | 43 | |
| 18 | 1999 | 79 | |
| 19 | 1998 | 39 | |
| 20 | Antibiotic prophylaxis in gastroduodenal surgery. | 1997 | 8 |
About Argyris Michalopoulos
Argyris Michalopoulos is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 99 papers that have together received 6.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (32 papers), Antibiotics Pharmacokinetics and Efficacy (22 papers), Pneumonia and Respiratory Infections (21 papers), Nosocomial Infections in ICU (20 papers), Cardiac, Anesthesia and Surgical Outcomes (16 papers), Antibiotic Use and Resistance (10 papers), Antifungal resistance and susceptibility (8 papers) and Sepsis Diagnosis and Treatment (8 papers). The work is most often cited by research in Molecular Medicine (2.9k citations), Applied Microbiology and Biotechnology (835 citations) and Critical Care and Intensive Care Medicine (1.0k citations). Argyris Michalopoulos has collaborated with scholars based in Greece, United States and Italy. Frequent co-authors include Matthew E. Falagas, Petros I. Rafailidis, Sofia K. Kasiakou, George Samonis, Ioannis A. Bliziotis, Stefanos Geroulanos, Drosos E. Karageorgopoulos, Spyros D. Mentzelopoulos, Sotirios Tsiodras and Elpidoforos S. Soteriades. Their work appears in journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.